Insmed Incorporated (INSM) is listed on NASDAQ in Pharmaceutical Stocks. It is $118.52, -2.36%, with a $25.9B market cap. RSI is 47.9, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 47.9 Neutral
Market Cap $25.9B
Volume 2.4M
Fundamentals — 10-Q Q2 2026
Revenue $731.5M
Net Income $-176.8M
EPS $-0.82
Gross Margin 84.3%
Operating Margin -21.2%
Net Margin -24.2%
Debt / Equity 0.7x
P/E Ratio -144.5x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Sharoky Melvin Md | Director | Sell | 5,000 | $127.53 | $637,650 | 2026 Aug 17 |
| Adsett Roger | Chief Operating Officer | Sell | 239,850 | $133.27 | $32.0M | 2026 Aug 10 |
| Flammer Martina M.d. | Chief Medical Officer | Sell | 27,173 | $128.61 | $3.5M | 2026 Aug 6 |
| Lewis William | Chair and CEO | Sell | 10,700 | $106.06 | $1.1M | 2026 Jul 23 |
| Lewis William | Chair and CEO | Sell | 10,699 | $117.40 | $1.3M | 2026 Jul 9 |
| Flammer Martina M.d. | Chief Medical Officer | Sell | 12,302 | $109.98 | $1.4M | 2026 Jul 6 |
| Lewis William | Chair and CEO | Sell | 21,398 | $103.32 | $2.2M | 2026 Jun 25 |
| Smith Michael Alexander | Chief Legal Officer | Sell | 1,806 | $95.82 | $173,051 | 2026 Jun 22 |
| Lewis William | Chair and CEO | Sell | 6,515 | $94.03 | $612,605 | 2026 Jun 8 |
| Flammer Martina M.d. | Chief Medical Officer | Sell | 4,424 | $102.90 | $455,248 | 2026 Jun 5 |
| Adsett Roger | Chief Operating Officer | Sell | 2,370 | $102.27 | $242,380 | 2026 Jun 3 |
| Smith Michael Alexander | Chief Legal Officer | Sell | 2,159 | $102.27 | $220,801 | 2026 Jun 3 |
| Lewis William | Chair and CEO | Sell | 7,605 | $102.27 | $777,763 | 2026 Jun 3 |
| Smith Michael Alexander | Chief Legal Officer | Sell | 6,149 | $108.47 | $666,982 | 2026 May 22 |
| Lewis William | Chair and CEO | Sell | 25,564 | $106.33 | $2.7M | 2026 May 18 |
| Flammer Martina M.d. | Chief Medical Officer | Sell | 18,333 | $116.12 | $2.1M | 2026 May 14 |
| Bonstein Sara | Chief Financial Officer | Sell | 8,272 | $116.18 | $961,041 | 2026 May 13 |
| Adsett Roger | Chief Operating Officer | Sell | 5,837 | $116.18 | $678,143 | 2026 May 13 |
| Smith Michael Alexander | Chief Legal Officer | Sell | 4,109 | $116.18 | $477,384 | 2026 May 13 |
| Lewis William | Chair and CEO | Sell | 13,283 | $116.18 | $1.5M | 2026 May 13 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $113.32 | 33.7 | -- |
| | $50.83 | 49.4 | -- |
| | $534.20 | 52.0 | $12.3B |
| | $60.85 | 58.2 | $26.8B |
| | $199.01 | 34.8 | $10.4B |
Take INSM further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put INSM in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Insmed Incorporated next reports.
Set alerts on INSM
Get notified when Insmed Incorporated hits your price targets or technical conditions are met.
Get Started Free